FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses After the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-2537
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Neoadjuvant Chemotherapy in Soft Tissue Sarcomas: Latest Evidence and Clinical Implications

Therapeutic Advances in Medical Oncology
Oncology
2017English

FDG PET Imaging of Childhood Sarcomas

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2009English

Role of FDG-PET/CT for Monitoring Soft Tissue Tumors

Oncology Letters
Cancer ResearchOncology
2014English

Matrix Metalloproteinase Expression in High Grade Soft Tissue Sarcomas

Oncology Reports
MedicineCancer ResearchOncology
2007English

Feasibility of Chemotherapy in Treatment of Adult Soft Tissue Sarcomas

Orthopedics & Traumatology
2005English

Chemotherapy in Pediatric-Type Soft-Tissue Sarcomas

Current Oncology
Oncology
2020English

T2 -Based MRI Delta-Radiomics Improve Response Prediction in Soft-Tissue Sarcomas Treated by Neoadjuvant Chemotherapy.

Journal of Magnetic Resonance Imaging
Nuclear MedicineRadiologyImaging
2018English

Locally Advanced Esophageal Adenocarcinoma: Response to Neoadjuvant Chemotherapy and Survival Predicted By[18F]FDG-Pet/Ct

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2012English

Early Metabolic Response Using FDG PET/CT and Molecular Phenotypes of Breast Cancer Treated With Neoadjuvant Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy